United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 6 minute read General business news Saga plc (LON:SAGA) expects FY26 profit beat, driven by cruises and insurance outperformance Saga plc raises FY26 profit guidance as cruise and holidays outperform and new insurance deals reshape strategy. Find out what this means for investors. byPallavi MadhirajuJanuary 31, 2026